pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release
Open Access
- 1 November 2012
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 7, 5781-5792
Abstract
Strontium carbonate nanoparticles (SCNs), a novel biodegradable nanosystem for the pH-sensitive release of anticancer drugs, were developed via a facile mixed solvent method aimed at creating smart drug delivery in acidic conditions, particularly in tumor environments. Structural characterization of SCNs revealed that the engineered nanocarriers were uniform in size and presented a dumbbell-shaped morphology with a dense mass of a scale-like spine coating, which could serve as the storage structure for hydrophobic drugs. Chosen as a model anticancer agent, etoposide was effectively loaded into SCNs based on a simultaneous process that allowed for the formation of the nanocarriers and for drug storage to be accomplished in a single step. The etoposide-loaded SCNs (ESCNs) possess both a high loading capacity and efficient encapsulation. It was found that the cumulative release of etoposide from ESCNs is acid-dependent, and that the release rate is slow at a pH of 7.4; this rate increases significantly at low pH levels (5.8, 3.0). Meanwhile, it was also found that the blank SCNs were almost nontoxic to normal cells, and ESCN systems were evidently more potent in antitumor activity compared with free etoposide, as confirmed by a cytotoxicity test using an MTT assay and an apoptosis test with fluorescence-activated cell sorter (FACS) analysis. These findings suggest that SCNs hold tremendous promise in the areas of controlled drug delivery and targeted cancer therapy.Keywords
This publication has 48 references indexed in Scilit:
- Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co- -lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumoursBiomaterials, 2012
- Block Copolymer Micelles with Pendant Bifunctional Chelator for Platinum Drugs: Effect of Spacer Length on the Viability of Tumor CellsBiomacromolecules, 2012
- A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systemsNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicinEuropean Journal of Pharmaceutical Sciences, 2011
- Effective Drug Delivery, In Vitro and In Vivo, by Carbon-Based Nanovectors Noncovalently Loaded with Unmodified PaclitaxelACS Nano, 2010
- Gold nanocages covered by smart polymers for controlled release with near-infrared lightNature Materials, 2009
- Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticlesNanotechnology, 2009
- Cancer nanotechnology: small, but heading for the big timeNature Reviews Drug Discovery, 2007
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000